J-Pharm OÜRegistered

16975324Private limited company (OÜ)Founded 2024

Key figures

1 312 552 €+5 468 866,7%
Revenue 2025
+5 468 866,7%
Average annual growth 2024–2025
0500 k1 m1,5 m20242025

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0100 k200 k300 k20242025
Quarterly figures
QuarterRevenueNumber of employeesLabour taxes
Q3 2026366 522 €413 640 €
Q2 2026454 774 €412 618 €
Q1 2026331 921 €413 600 €
Q4 2025423 646 €413 655 €
Q3 2025299 977 €413 351 €
Q2 2025407 705 €68623 €
Q1 2025101 229 €5497 €

Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.

Summary of financial statements2024–2025
20242025
Balance sheet — assets
Total current assets6681283 897
Total non-current assets61655615
Total assets12 846289 512
Balance sheet — liabilities and equity
Current liabilities5534283 922
Non-current liabilities80000
Total liabilities13 534283 922
Share capital25002500
Retained earnings of previous periods—−3188
Profit for the year−31886278
Total equity−6885590
Income statement
Sales revenue241 312 552
Operating profit−31885061
EBITDA—6286
Profit before income tax−31886278
Profit for the reporting year−31886278
Labour costs0105 220
Depreciation of non-current assets—1225
Other indicators
Employees05
Calculated dividend—0

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Risks and obligationsAll clear
Register status
Registered
Business Register
Tax debt
None
Tax and Customs Board list of tax debtors
Enforcement and official notices
None
Official Announcements (Ametlikud Teadaanded)
Annual report filing
2/2 filed
All on time
Business Register · 2024–2025
Share pledges and disposal bans
None
Business Register

Data from public registers, not a credit rating.

Connections graph
100%J-Pharm OÜJekaterina Jung
CompanyPersonShareholderOther roleAdditional link

Public procurement

1 contracts

Public contracts won worth 500 000 € from 1 contracting authorities (23.01.2025–23.01.2025).

Source: Public Procurement Register open data from October 2023. All public tenders

Annual reportsPDF, XBRL

Loading list of reports…

Source: e-Business Register (RIK). Files open/download directly from the official register.

Summary: J-Pharm OÜ

Overview

J-Pharm OÜ (registry code 16975324) is a private limited company (OÜ). The company was entered in the Commercial Register in 2024 and has been registered for 2 years. Registered location: Lasnamäe linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is ravimite jaemüük (EMTAK 47731). The company is registered for VAT (VAT number EE102797305).

Financial results

Revenue in financial year 2025 was 1 312 552 €, up 5 468 867% on the previous year (24 €). Net profit for financial year 2025 was 6278 € (0,5% of revenue). In financial year 2025 the company had 5 employees (0 a year earlier). Revenue per employee was 262 510 €. At the end of financial year 2025, total assets were 289 512 € and equity 5590 € (1,9% of assets).

Latest quarterly figures

According to the Tax and Customs Board, turnover in Q3 2026 was 366 522 €, up 22,2% on the same quarter a year earlier. The company had 4 employees in that quarter. Labour taxes paid in the quarter: 13 640 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 2150 € per month.

Management and owners

The company has one management board member. The sole owner of the company is a private individual.

Data sources and freshness

Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 19.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.

Related companies